Humanase
Developer of human organ‑mimicking microfluidic chips for in‑vitro drug efficacy, toxicity and disease‑modeling. The company builds vascularized, 3D co‑culture organ models (brain, heart, liver, tumor/immune, bone and multi‑organ combinations), provides research/analysis services for candidate compounds, and positions its platform as an alternative to some animal experiments.
Industries
Nr. of Employees
small (1-50)
Products
Brain model using organ‑on‑a‑chip
3D brain microphysiological model using human pluripotent stem cell‑derived neurons and astrocytes with vascular transport to assess neurotoxicity and neurodegenerative disease phenotypes.
Heart model using organ‑on‑a‑chip
3D cardiac microenvironment using human iPSC‑derived cardiomyocytes to evaluate cardiac efficacy, arrhythmia and cardiotoxicity.
Liver model using organ‑on‑a‑chip
Microphysiological liver model reproducing liver microstructure and zonation for hepatotoxicity, protein secretion and metabolic studies.
Tumor and tumor–immune interaction models on chip
Microenvironmental chips that recapitulate complex tumor microenvironments and tumor–immune cell interactions to support anticancer and immuno‑oncology research.
Bone (osteoporosis) modeling chip
Bone‑mimicking chip that includes vascular components and bone cell types (osteoblasts, osteoclasts, osteocytes) for osteoporosis and bone disease modeling.
Brain model using organ‑on‑a‑chip
3D brain microphysiological model using human pluripotent stem cell‑derived neurons and astrocytes with vascular transport to assess neurotoxicity and neurodegenerative disease phenotypes.
Heart model using organ‑on‑a‑chip
3D cardiac microenvironment using human iPSC‑derived cardiomyocytes to evaluate cardiac efficacy, arrhythmia and cardiotoxicity.
Liver model using organ‑on‑a‑chip
Microphysiological liver model reproducing liver microstructure and zonation for hepatotoxicity, protein secretion and metabolic studies.
Tumor and tumor–immune interaction models on chip
Microenvironmental chips that recapitulate complex tumor microenvironments and tumor–immune cell interactions to support anticancer and immuno‑oncology research.
Bone (osteoporosis) modeling chip
Bone‑mimicking chip that includes vascular components and bone cell types (osteoblasts, osteoclasts, osteocytes) for osteoporosis and bone disease modeling.
Services
Contract evaluation of candidate drugs and functional compounds using organ‑mimicking chips to assess efficacy and organ‑specific toxicity.
Contract evaluation of candidate drugs and functional compounds using organ‑mimicking chips to assess efficacy and organ‑specific toxicity.
Expertise Areas
- Organ‑on‑a‑chip platforms
- In‑vitro disease modeling
- Drug efficacy and toxicity testing
- Human iPSC differentiation and use in assays
Key Technologies
- Organ‑on‑a‑chip
- Microfluidics (vascularized channels)
- 3D co‑culture and organoid techniques
- Human iPSC‑derived cell differentiation
News & Updates
Received an industry award in the organ‑mimicking chip category at a national industry awards ceremony.
Selected for a government startup acceleration project (초격차 스타트업 1000+).
Awarded selection for bio/medical technology development funding to advance organ‑mimicking chip development as an alternative to animal experiments.
Received an industry award in the organ‑mimicking chip category at a national industry awards ceremony.
Selected for a government startup acceleration project (초격차 스타트업 1000+).
Awarded selection for bio/medical technology development funding to advance organ‑mimicking chip development as an alternative to animal experiments.